Financials

  • Market Capitalization 148.15 M
  • Employee 9
  • Founded 2017
  • CEO N/A
  • Website www.nervgen.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00NQ5C032
  • Industry N/A

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3723
MENS
Jyong Biotech Ltd. - Ordinary shares
2.30 USD+4.07%+5.02%+45.57%-80.43%174.86 M USD
3797
FLX
BingEx Limited - American Depositary Shares
2.12 USD-2.75%+1.92%-3.20%-16.21%155.04 M USD
3845
MSLE
Satellos Bioscience Inc. - Common Stock
8.90 USD-2.41%+12.23%+53.45%-23.61%137.58 M USD
3998
EDHL
Everbright Digital Holding Limited - Ordinary Shares
3.63 USD-8.56%-24.69%-51.28%+327.06%96.78 M USD

Frequently asked questions about NervGen Pharma Corp. - Common stock

What is the NervGen Pharma Corp. - Common stock stock price today?

The current price of NervGen Pharma Corp. - Common stock (NGEN) is 1.8599999999999999. Over the past 24 hours, the stock has changed by -3.63%. Follow the NGEN chart for real-time price dynamics.

What is the stock ticker of NervGen Pharma Corp. - Common stock?

NervGen Pharma Corp. - Common stock trades under the ticker NGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is NervGen Pharma Corp. - Common stock stock going up?

NGEN has changed by -9.71% over the last week, -4.62% over the last month, and -70.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does NervGen Pharma Corp. - Common stock have?

As of the latest available data, NervGen Pharma Corp. - Common stock has 9 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy NervGen Pharma Corp. - Common stock stock?

You can buy NervGen Pharma Corp. - Common stock (NGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in NervGen Pharma Corp. - Common stock stock?

Investing in NervGen Pharma Corp. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NGEN chart and related analysis on metatrader.com as part of your research.